Breast Cancer Management (ISSN: 1758-1923)

Description

Screening programs, better treatments and a general increase in awareness have resulted in declining death rates from breast cancer over the past two decades. However, in developed countries, the disease remains the second leading cause of cancer death in women after lung cancer. The chance of developing invasive breast cancer at some time in a woman's life is approximately 1 in 8, and the chance that breast cancer will be responsible for a woman's death is about 1 in 35.
Effective management of this relatively common disease can therefore have a significant impact on survival at the population level, and have a profound effect on lives of those directly affected by the disease and their loved ones.
Breast Cancer Management addresses key issues in disease management by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal also highlights significant advances in basic and translational research, and places them in context for future therapy.
Breast Cancer Management provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease. Recent research findings and advances clinical practice in the field are reported and analyzed by international experts. The journal presents this information in clear, accessible formats.
All articles are subject to independent review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.
Coverage includes:
Diagnosis and imaging
Surgical approaches
Radiotherapy
Systemic therapies
Cancer clinical trials
Genetic aspects of disease
Personalized medicine
Translational research and biomarker studies
Management of psychological distress
Epidemiological studies
Pharmacoeconomics
Evidence-based treatment guidelines